NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
0.5900
+0.0052 (0.89%)
At close: Aug 13, 2025, 4:00 PM
0.6188
+0.0288 (4.88%)
Pre-market: Aug 14, 2025, 8:00 AM EDT

NovaBay Pharmaceuticals Market Cap

NovaBay Pharmaceuticals has a market cap or net worth of $3.43 million as of August 14, 2025. Its market cap has increased by 328.95% in one year.

Market Cap
3.43M
Enterprise Value
-3.91M
1-Year Change
328.95%
Ranking
Category
Stock Price
$0.59

Market Cap Chart

Since October 26, 2007, NovaBay Pharmaceuticals's market cap has decreased from $76.50M to $3.43M, a decrease of -95.51%. That is a compound annual growth rate of -16.00%.

History

DateMarket Cap% Change
Aug 12, 20253.40M17.24%
Dec 31, 20242.90M123.08%
Dec 29, 20231.30M-63.89%
Dec 30, 20223.60M-78.70%
Dec 31, 202116.90M-41.92%
Dec 31, 202029.10M62.57%
Dec 31, 201917.90M35.61%
Dec 31, 201813.20M-77.70%
Dec 29, 201759.20M18.64%
Dec 30, 201649.90M612.86%
Dec 31, 20157.00M-78.46%
Dec 31, 201432.50M-32.85%
Dec 31, 201348.40M43.62%
Dec 31, 201233.70M-11.32%
Dec 30, 201138.00M-1.81%
Dec 31, 201038.70M-19.21%
Dec 31, 200947.90M118.72%
Dec 31, 200821.90M-72.59%
Dec 31, 200779.90M4.44%
View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 568.72B
Johnson & Johnson 418.79B
AbbVie 352.25B
UnitedHealth Group 234.39B
AstraZeneca 229.47B
Novartis AG 228.69B
Abbott Laboratories 227.58B
Novo Nordisk 222.88B
Market Cap Rankings